Cem Akin, MD, PhD Consultant/Advisor: Blueprint Medicines, Novartis, Patara Pharma; Supported/Contracted Research: Dyax | Thomas B. Casale, MD, FACAAI Consultant/Advisor: AstraZeneca, Genentech, Novartis, Sanofi, Teva |
Craig A. Alter, MD Consultant/Advisor: Pfizer | Bradley E. Chipps, MD, FACAAI Consultant/Advisor: AstraZeneca, Boehringer Ingelheim, Genentech, Merck, Novartis; Speaker: AstraZeneca, Boehringer Ingelheim, Genentech, Merck, Novartis; Supported/Contracted Research: Stallergenes |
Leonard B. Bacharier, MD, FACAAI Consultant/Advisor: Boehringer Ingelheim, DBV Technologies, GlaxoSmithKline, Meda,Teva; Speaker: AstraZeneca, Novartis | Ray S. Davis, MD, FACAAI Consultant/Advisor: Alcon, AstraZeneca, Baxter, Meda, Merck, Teva |
Mark M. Ballow, MD, FACAAI Consultant/Advisor: CSL Behring, Kedrion; Supported/ Contracted Research: CSL Behring; Speaker: Baxter | § Chitra Dinakar, MD, FACAAI Consultant/Advisor: Aerocrine; Supported/Contracted Research: GlaxoSmithKline, Merck, Teva |
Gregory W. Bensch, MD, FACAAI Consultant/Advisor: AstraZeneca, Teva; Supported/ Contracted Research: AstraZeneca, Boehringer Ingelheim, Pearl, Teva | Mark S. Dykewicz, MD, FACAAI Consultant/Advisor: Merck; Supported/Contracted Research: Novartis |
J. Andrew Bird, MD, FACAAI Speaker: Nutrica; Supported/Contracted Research: Aimmune Therapeutics, DBV Technologies | David B. Engler, MD, FACAAI Stock: Regeneron |
Mark Boguniewicz, MD, FACAAI Consultant/Advisor: Celgene, Regeneron; Supported/ Contracted Research: Anacor | Elizabeth A. Erwin, MD Stock: Pfizer |
Larry Borish, MD, FACAAI Consultant/Advisor: Allakos, Knopp, Novartis, PluriStem | Stanley M. Fineman, MD, MBA, FACAAI Speaker: AstraZeneca, Genentech, Meda, Merck, Mylan; Supported/Contracted Research: Genentech, Meda |
John C. Browning, MD, MBA Supported/Contracted Research: Anacor, MedImmune, Regeneron | David M. Fleisher, MD Consultant/Advisor: Food Allergy Research & Education, LabCorp, National Peanut Board, Receptors, Nestle Nutrition Institute; Supported/ Contracted Research: Monsanto Company, Nestle Nutrition Institute |
A. Wesley Burks, MD, FACAAI Consultant/Advisor: Dynavax Technologies, Genentech, GLG Research, Intrexon, Perrigo, Perosphere, Regeneron, SRA International, Sanofi, Valeant; Board Member (for profit organization) Stallergenes | § Luz S. Fonacier, MD, FACAAI Speaker: Baxter; Supported/Contracted Research: Baxter, Genentech, Merck |
§ B. Gwen Carlton, DNP, APRN, FNP-BC Speaker: Genentech | David M. Lang, MD, FACAAI Consultant/Advisor: Genentech, GlaxoSmithKline, Meda, Merck; Speaker: Genentech; Supported/ Contracted Research: Genentech, Merck |
Lene Heise Garvey, MD, PhD Consultant/Advisor: Merck; Speaker: Thermo Fisher Scientific | Bob Lanier, MD, FACAAI Supported/Contracted Research: Merck, Novartis, Teva; Speaker: Genentech, Merck |
Maureen George, PhD, RN, AE-C Consultant/Advisor: Teva; Speaker: Teva | § Phillip L. Lieberman, MD, FACAAI Consultant/Advisor: Genentech, Mylan, Teva, Valeant; Speaker: Meda |
§ Richard G. Gower, MD, FACAAI Consultant/Advisor: CSL Behring, Dyax, Mylan, Shire, Teva; Medical Director: HollisterStier; Speaker: CSL Behring, Mylan, Shire, Teva; Supported/Contracted Research: Anacor, Biocryst, Circassia, CSL Behring, Dyax, Genentech, GlaxoSmithKline, Kedrion, Mylan, Optinose, Pearl, Regeneron, Shire, Teva; Stock: Merck | Peter A. Lio, MD Consultant/Advisor: Anacor, Galderma, Johnson & Johnson, Pierre Fabre, Valeant |
David F. Graft, MD, FACAAI Consultant/Advisor: Aerocrine; Speaker: Merck | William R. Lumry, MD, FACAAI Consultant/Advisor: Biocryst, CSL Behring, Dyax, Shire; Speaker: CSL Behring, Dyax, Shire, Teva; Supported/ Contracted Research: ADMA Biologics, Biocryst, Circassia, CSL Behring, Dyax, Kedrion, Mylan, Novartis, Roche, Shire, Teva |
Mitchell H. Grayson, MD, FACAAI Supported/Contracted Research: Polyphor | § Todd A. Mahr, MD, FACAAI Speaker: Aerocrine, Genentech, GlaxoSmithKline, Meda, Merck, Mylan, Sanofi, Teva |
§ Matthew Greenhawt, MD, MBA, MSc, FACAAI Consultant/Advisor: National Peanut Board; Supported/Contracted Research: National Center for Translational Sciences | Michael E. Manning, MD, FACAAI Consultant/Advisor: Dyax, Shire; Speaker: Baxter, CSL Behring, Dyax, Genentech, Merck, Shire; Supported/ Contracted Research: Amgen, AstraZeneca, Biocryst, Dyax, Genentech, Janssen, Johnson & Johnson, Merck, Novartis, Sanofi, Shire, Teva |
Gary N. Gross, MD, FACAAI Supported/Contracted Amgen, Genentech, Janssen, Mylan, Perrigo, Sanofi, Teva; Speaker: Merck, Teva | Kelly M. Maples, MD, FACAAI Speaker: Teva |
Ruchi Gupta, MD, MPH Speaker: Mylan Specialty; Supported/Contracted Research: Food Allergy Research & Education, Mylan | Gailen D. Marshall, MD, PhD, FACAAI Supported/Contracted Research: Amgen, AstraZeneca, National Institutes of Health (NIH) |
Nicola A. Hanania, MD, MS Consultant/Advisor: AstraZeneca, Meda, Novartis, Pfizer, Roche, Sunovion; Speaker: Genentech; Supported/Contracted Research: Boehringer Ingelheim, Chiesi, Genentech, GlaxoSmithKline, Mylan, Novartis, Pfizer, Roche, Sunovion | • § Kevin P. McGrath, MD FACAAI Speaker: Teva |
Mary Lou Hayden, MSN, FNP-BC, AE-C Consultant/Advisor: Boehringer Ingelheim, Mylan, Teva | J. Allen Meadows, MD, FACAAI Consultant/Advisor: Pfizer; Stocks: Johnson & Johnson |
Erika Jensen-Jarolim, MD Speaker: Allergy Therapeutics, Meda, Roxall, Thermo Fisher Scientific; Stocks: Biomedical International R&D Vienna, AllergyCare Vienna | Eli O. Meltzer, MD, FACAAI Consultant/Advisor: AstraZeneca, Boehringer Ingelheim, Circassia, GlaxoSmithKline, Greer, Johnson & Johnson, McNeill, Meda, Merck, Regeneron, Sanofi, Sunovion, Teva, Takeda, Valeant; Speaker: Alcon, Greer, Meda, Mylan, Sunovion, Teva, Takeda |
§ Rohit K. Katial, MD, FACAAI Consultant/Advisor: AstraZeneca, GlaxoSmithKline, Meda, Teva; Speaker: GlaxoSmithKline, Meda | Anthony Montanaro, MD, FACAAI Supported/Contracted Reearch: Circassia, Genentech, GlaxoSmithKline, Merck, Teva |
§ David A. Khan, MD, FACAAI Speaker: Baxter, Genentech | Harold S. Nelson, MD, FACAAI Consultant/Advisor: AstraZeneca, Circassia, Merck, Pearl Therapeutics; Supported/Contracted Research: Circassia |
Lisa K. Kobrynski, MD, MPH, FACAAI Supported/Contracted Research: Baxter; Speaker: Baxter, CSL Behring | William S. Silvers, MD, FACAAI Speaker: Teva |
Jerald W. Koepke, MD, FACAAI Supported/Contracted Research: Sanofi | Roland Solensky, MD Supported/Contracted Research: AstraZeneca, Merck |
Anna H. Nowak-Wegrzyn, MD, FACAAI Consultant/Advisor: Merck, Nestle; Speaker: Sanofi; Supported/Contracted Research: DBV Technologies, Food Allergy Research & Education, NIH/NIAID, ITN, Nutricia | § Brett Stanaland, MD, FACAAI Speaker: Alcon, Meda, Merck, Teva |
Talal M. Nsouli, MD, FACAAI Consultant/Advisor: Teva; Speaker: Perrigo, Thermo Fisher Scientific | § James L. Sublett, MD, FACAAI Consultant/Advisor: Boston Scientific, Greer; Speaker: Genentech, GlaxoSmithKline, Meda, Merck, Sunovion, Teva; Supported/Contracted Research: Array BioPharma, AstraZeneca, Boehringer Ingelheim, Forest, Mylan, Sanofi: Stock: AllergyZone |
§ Maeve E. O’Connor, MD, FACAAI Consultant/Advisor: Novartis; Speaker: Aerocrine, Baxter, Dyax, Greer, Meda, Merck, Mylan, Teva, Thermo Fisher Scientific | § Stephen A. Tilles, MD, FACAAI Supported/Contracted Research: Amgen, Astellas, AstraZeneca, Biota, Circassia, DBV Technologies, Genentech, Merck, Mylan, Novartis, Perrigo, Teva |
§ John J. Oppenheimer, MD, FACAAI Consultant/Advisor: GlaxoSmithKline, Meda, Mylan; Supported/Contracted Research: AstraZeneca, MedImmune, Novartis | James M. Tracy, DO, FACAAI Consultant/Advisor: Johnson and Johnson, Pfizer; Stock: Johnson & Johnson |
Jordan S. Orange, MD, PhD, FACAAI Consultant/Advisor: ADMA Biologics, ASD Healthcare, Baxter, CSL Behring, Walgreens | Carina Venter, PhD, RD Consultant/Advisor: Mead Johnson, Nestle; Speaker: Nutricia; Supported/Contracted Research: Thermo Fisher Scientific |
Reynold A. Panettieri, Jr., MD Consultant/Advisor: AstraZeneca, Johnson & Johnson; Supported/Contracted Research: Gilead, Johnson & Johnson, Merck, Roche, Sanofi | Christine W. Wagner, MSN, RN, CPNP, AE-C Speaker: Teva |
Anju T. Peters, MD, FACAAI Consultant/Advisor: Baxter, Greer, Meda; Speaker: Celgene | Julie Wang, MD, FACAAI Consultant/Advisor: JDP Therapeutics, Merck |
Stephen P. Peters, MD, PhD Consultant/Advisor: AstraZeneca, Boehringer Ingelheim, CSL Behring, Gilead, Merck, Novartis, Pfizer, Teva, PPD Development, Quintiles, Theron | Richard L. Wasserman, MD, PhD, FACAAI Consutlant/Advisor: ADMA Biologics, Baxter, Bio Products Lab, CSL Behring, Grifols, Kedrion, ProMetic, Therapure Biopharma; Speaker: Baxter, CSL Behring; Supported/Contracted Research: ADMA Biologics, Baxter, Bio Products Labs, CSL Behring, Kedrion, Merck, Perrigo, Sanofi, Teva |
§ Michael Pistiner, MD, MMSc, FACAAI Stock: AllergyHome.org | Stephen I. Wasserman, MD, FACAAI President: ABAI; consultant(sp): Pathway Genomics |
Jay M. Portnoy, MD, FACAAI Speaker: Mylan, Thermo Fisher Scientific | Richard W. Weber, MD, FACAAI Consultant/Advisor: Genentech; Speaker: AstraZeneca, Meda, Merck |
Marc A. Riedl, MD, MS Consultant/Advisor: Baxter, BioCryst, CSL Behring, Dyax, Salix, Shire: Speaker: Baxter, CSL Behring, Dyax, Salix, Shire: Supported/Contracted Research: Amgen, Biocryst, CSL Behring, Dyax, Shire | Bruce L. Zuraw, MD, FACAAI Consultant/Advisor: BioCryst, CSL Behring, Dyax, Genentech, Isis, Novartis, Sanofi, Shire |
§ Deidra H. Sanders, MSN, APRN, FNP-BC Consultant/Advisor: Meda; Stock: AllergyZone | |
§ Charles J. Siegel, MD, FACAAI Consultant/Advisor: Meda; Speaker: Meda, Teva | |
| |
• = Planner §= Moderator | |